| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 662-666, Copyright © 1994 by Endocrine Society
ARTICLES |
SR Hoelscher and M Ascoli
Department of Pharmacology, University of Iowa College of Medicine, Iowa City 52242.
Although hCG and mouse epidermal growth factor activate different signaling systems in a clonal strain of Leydig tumor cells (designated MA-10), both compounds are capable of increasing steroidogenesis, decreasing transcription of the LH/CG receptor gene, and attenuating adenylyl cyclase. We have recently identified a 21-kilodalton protein (p21) that is a potential intermediary in the actions of mouse epidermal growth factor and hCG. Characterization of p21 revealed similarities to stathmin, a ubiquitous phosphoprotein whose phosphorylation is associated with diverse second messenger pathways. Using two different experimental approaches, Western blotting and immunoprecipitation, we present data that identify p21 as stathmin.
This article has been cited by other articles:
![]() |
T. Wittmann, G. M. Bokoch, and C. M. Waterman-Storer Regulation of Microtubule Destabilizing Activity of Op18/Stathmin Downstream of Rac1 J. Biol. Chem., February 13, 2004; 279(7): 6196 - 6203. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Manna, I. T. Huhtaniemi, X.-J. Wang, D. W. Eubank, and D. M. Stocco Mechanisms of Epidermal Growth Factor Signaling: Regulation of Steroid Biosynthesis and the Steroidogenic Acute Regulatory Protein in Mouse Leydig Tumor Cells Biol Reprod, November 1, 2002; 67(5): 1393 - 1404. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |